rs9332969
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_000044.6(AR):c.2522G>A(p.Arg841His) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R841C) has been classified as Pathogenic.
Frequency
Consequence
NM_000044.6 missense
Scores
Clinical Significance
Conservation
Publications
- androgen insensitivity syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- Kennedy diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- partial androgen insensitivity syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- complete androgen insensitivity syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Observed in several unrelated patients with androgen insensitivity syndrome in published literature (McPhaul et al., 1992; Beitel et al., 1994); Published functional studies demonstrate a damaging effect on GH gene promotion as well as ligand binding (Beitel et al., 1994); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 32985417, 3605226, 8040309, 28624954, 1430233, 28186600, 25241384, 16450583, 15835798, 27267075) -
- -
Androgen resistance syndrome Pathogenic:2
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.91 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.95 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009829 /PMID: 1430233 /3billion dataset). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 1430233, 16450583, 25241384, 28624954, 32985417). Different missense changes at the same codon (p.Arg841Cys, p.Arg841Gly, p.Arg841Ser) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009830 /PMID: 10502786, 1430233, 9856504). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
Experimental studies have shown that this missense change affects AR function (PMID: 1430233, 8040309). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 841 of the AR protein (p.Arg841His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with androgen insensitivity syndome (PMID: 1430233, 8040309, 16450583, 25241384, 27267075, 28186600, 28624954). It has also been observed to segregate with disease in related individuals. This variant is also known as p.R838H, p.R839H, and p.R840H. ClinVar contains an entry for this variant (Variation ID: 9829). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AR protein function. This variant disrupts the p.Arg941 amino acid residue in AR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1430233, 8040309, 8824883, 11788673, 15925895, 20011049). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Partial androgen insensitivity syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at